Greif's fiscal second quarter 2024 results revealed a decrease in net income and adjusted EBITDA compared to the prior year. However, the company highlighted progress on its Build to Last Strategy, including the acquisition of Ipackchem, and noted signs of demand improvement in key regions.
Net income decreased 60.1% to $44.4 million, or $0.77 per diluted Class A share.
Adjusted EBITDA decreased 25.7% to $169.9 million.
Net sales increased to $1,371.0 million from $1,308.9 million.
Completed acquisition of Ipackchem.
Greif anticipates adjusted EBITDA to be between $675 million and $725 million and adjusted free cash flow to be between $175 million and $225 million for fiscal year 2024.
Visualization of income flow from segment revenue to net income